Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure

S. J. Siskind, E. H. Sonnenblick, Robert Forman, J. Scheuer, T. H. LeJemtel

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The acute hemodynamic and metabolic effects of amrinone during exercise were studied in eight patients with severe congestive heart failure. The patients exercised to exhaustion on an upright bicycle ergometer at a fixed work load of 25 W. During the control period of exercise, exhaustion occurred at 3.16±1.39 minutes. Stroke volume increased from 29.5±5.8 to 38.7±9.5 ml (p<0.01), arteriovenous oxygen difference from 7.6±1.3 to 9.6±0.6 ml/100 ml (p<0.001), oxygen consumption from 231±38 to 468±111 ml/min (p<0.001) and arterial lactate concentration from 1.07±0.25 to 5.02±1.45 mmol/l (p<0.01). During exercise after administration of amrinone, exhaustion occurred significantly later than during the control period: 6.28±2.07 vs 3.16±1.39 minutes (p<0.05). At a time equal to the point of exhaustion during the control period, stroke volume was significantly greater amrinone (46.7±9.8 vs 38.7±9.5 ml, p<0.05), arteriovenous oxygen difference and arterial lactate concentration were significantly lower (7.7±0.9 vs 9.6±0.6 ml/100 ml [p<0.05] and 2.96±1.01 vs 5.02±1.45 mmol/l [p<0.05], respectively) and oxygen consumption was similar. At the point of exhaustion during exercise after amrinone, there were further increases in stroke volume (to 54.0±11.6 ml, p<0.05), and oxygen consumption (to 674±141 ml/min, p<0.05), while arteriovenous oxygen difference and arterial lactate concentration reached values similar to those during control exercise. Thus, amrinone increased exercise capacity, improved exercise hemodynamics, and probably decreased anaerobic metabolism at a given duration of exercise.

Original languageEnglish (US)
Pages (from-to)966-973
Number of pages8
JournalCirculation
Volume64
Issue number5
StatePublished - 1981

Fingerprint

Amrinone
Heart Failure
Hemodynamics
Exercise
Oxygen Consumption
Stroke Volume
Lactic Acid
Therapeutics
Oxygen
Anaerobiosis
Workload

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure. / Siskind, S. J.; Sonnenblick, E. H.; Forman, Robert; Scheuer, J.; LeJemtel, T. H.

In: Circulation, Vol. 64, No. 5, 1981, p. 966-973.

Research output: Contribution to journalArticle

Siskind, S. J. ; Sonnenblick, E. H. ; Forman, Robert ; Scheuer, J. ; LeJemtel, T. H. / Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure. In: Circulation. 1981 ; Vol. 64, No. 5. pp. 966-973.
@article{a1be75e0b4da4df8b0ce96d9ee7c2fe0,
title = "Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure",
abstract = "The acute hemodynamic and metabolic effects of amrinone during exercise were studied in eight patients with severe congestive heart failure. The patients exercised to exhaustion on an upright bicycle ergometer at a fixed work load of 25 W. During the control period of exercise, exhaustion occurred at 3.16±1.39 minutes. Stroke volume increased from 29.5±5.8 to 38.7±9.5 ml (p<0.01), arteriovenous oxygen difference from 7.6±1.3 to 9.6±0.6 ml/100 ml (p<0.001), oxygen consumption from 231±38 to 468±111 ml/min (p<0.001) and arterial lactate concentration from 1.07±0.25 to 5.02±1.45 mmol/l (p<0.01). During exercise after administration of amrinone, exhaustion occurred significantly later than during the control period: 6.28±2.07 vs 3.16±1.39 minutes (p<0.05). At a time equal to the point of exhaustion during the control period, stroke volume was significantly greater amrinone (46.7±9.8 vs 38.7±9.5 ml, p<0.05), arteriovenous oxygen difference and arterial lactate concentration were significantly lower (7.7±0.9 vs 9.6±0.6 ml/100 ml [p<0.05] and 2.96±1.01 vs 5.02±1.45 mmol/l [p<0.05], respectively) and oxygen consumption was similar. At the point of exhaustion during exercise after amrinone, there were further increases in stroke volume (to 54.0±11.6 ml, p<0.05), and oxygen consumption (to 674±141 ml/min, p<0.05), while arteriovenous oxygen difference and arterial lactate concentration reached values similar to those during control exercise. Thus, amrinone increased exercise capacity, improved exercise hemodynamics, and probably decreased anaerobic metabolism at a given duration of exercise.",
author = "Siskind, {S. J.} and Sonnenblick, {E. H.} and Robert Forman and J. Scheuer and LeJemtel, {T. H.}",
year = "1981",
language = "English (US)",
volume = "64",
pages = "966--973",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure

AU - Siskind, S. J.

AU - Sonnenblick, E. H.

AU - Forman, Robert

AU - Scheuer, J.

AU - LeJemtel, T. H.

PY - 1981

Y1 - 1981

N2 - The acute hemodynamic and metabolic effects of amrinone during exercise were studied in eight patients with severe congestive heart failure. The patients exercised to exhaustion on an upright bicycle ergometer at a fixed work load of 25 W. During the control period of exercise, exhaustion occurred at 3.16±1.39 minutes. Stroke volume increased from 29.5±5.8 to 38.7±9.5 ml (p<0.01), arteriovenous oxygen difference from 7.6±1.3 to 9.6±0.6 ml/100 ml (p<0.001), oxygen consumption from 231±38 to 468±111 ml/min (p<0.001) and arterial lactate concentration from 1.07±0.25 to 5.02±1.45 mmol/l (p<0.01). During exercise after administration of amrinone, exhaustion occurred significantly later than during the control period: 6.28±2.07 vs 3.16±1.39 minutes (p<0.05). At a time equal to the point of exhaustion during the control period, stroke volume was significantly greater amrinone (46.7±9.8 vs 38.7±9.5 ml, p<0.05), arteriovenous oxygen difference and arterial lactate concentration were significantly lower (7.7±0.9 vs 9.6±0.6 ml/100 ml [p<0.05] and 2.96±1.01 vs 5.02±1.45 mmol/l [p<0.05], respectively) and oxygen consumption was similar. At the point of exhaustion during exercise after amrinone, there were further increases in stroke volume (to 54.0±11.6 ml, p<0.05), and oxygen consumption (to 674±141 ml/min, p<0.05), while arteriovenous oxygen difference and arterial lactate concentration reached values similar to those during control exercise. Thus, amrinone increased exercise capacity, improved exercise hemodynamics, and probably decreased anaerobic metabolism at a given duration of exercise.

AB - The acute hemodynamic and metabolic effects of amrinone during exercise were studied in eight patients with severe congestive heart failure. The patients exercised to exhaustion on an upright bicycle ergometer at a fixed work load of 25 W. During the control period of exercise, exhaustion occurred at 3.16±1.39 minutes. Stroke volume increased from 29.5±5.8 to 38.7±9.5 ml (p<0.01), arteriovenous oxygen difference from 7.6±1.3 to 9.6±0.6 ml/100 ml (p<0.001), oxygen consumption from 231±38 to 468±111 ml/min (p<0.001) and arterial lactate concentration from 1.07±0.25 to 5.02±1.45 mmol/l (p<0.01). During exercise after administration of amrinone, exhaustion occurred significantly later than during the control period: 6.28±2.07 vs 3.16±1.39 minutes (p<0.05). At a time equal to the point of exhaustion during the control period, stroke volume was significantly greater amrinone (46.7±9.8 vs 38.7±9.5 ml, p<0.05), arteriovenous oxygen difference and arterial lactate concentration were significantly lower (7.7±0.9 vs 9.6±0.6 ml/100 ml [p<0.05] and 2.96±1.01 vs 5.02±1.45 mmol/l [p<0.05], respectively) and oxygen consumption was similar. At the point of exhaustion during exercise after amrinone, there were further increases in stroke volume (to 54.0±11.6 ml, p<0.05), and oxygen consumption (to 674±141 ml/min, p<0.05), while arteriovenous oxygen difference and arterial lactate concentration reached values similar to those during control exercise. Thus, amrinone increased exercise capacity, improved exercise hemodynamics, and probably decreased anaerobic metabolism at a given duration of exercise.

UR - http://www.scopus.com/inward/record.url?scp=0019443089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019443089&partnerID=8YFLogxK

M3 - Article

C2 - 7285310

AN - SCOPUS:0019443089

VL - 64

SP - 966

EP - 973

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 5

ER -